NightHawk Biosciences, Inc.

AMEX:NHWK

0.4416 (USD) • At close November 17, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q1
Revenue 0.7230.6580.7666,376.9255.9810.0510.2120.6130.5020.4590.5390.6030.850.5930.9021.9990.0060.3420.7012.0581.841.1430.7530.6140.4710.4110.0240.1210.220000000000000000.0030.0030
Cost of Revenue 0.5450.3840.6120.0386.3630.5380.2290.2124.3824.2163.4064.1933.1732.7912.7833.2883.1293.4243.1725.4774.4043.482.8732.4791.8242.1521.8132.2031.6931.7763.6587.1013.7193.3742.1692.031.2591.1130.8460.6490.2310.4550.0620.0530.05300
Gross Profit 0.1780.2740.1546,376.886-0.382-0.487-0.0160.401-3.88-3.757-2.868-3.59-2.323-2.198-1.881-1.289-3.123-3.082-2.471-3.418-2.564-2.337-2.12-1.865-1.353-1.741-1.789-2.082-1.473-1.776-3.658-7.101-3.719-3.374-2.169-2.03-1.259-1.113-0.846-0.649-0.231-0.455-0.062-0.053-0.050.0030
Gross Profit Ratio 0.2460.4170.2011-0.064-9.553-0.0760.654-7.736-8.176-5.324-5.951-2.734-3.705-2.085-0.645-485-8.998-3.525-1.661-1.393-2.044-2.818-3.04-2.874-4.233-73.79-17.147-6.688000000000000000-15.99710
Reseach & Development Expenses 5.1555.7336.9967.946.8614.7273.9336.8174.3824.2163.4064.1933.1732.7912.7833.2883.1293.4243.1725.4774.4043.482.8732.4791.8242.1521.8137.8160.5590.4550.50.8270.6770.5870.5040.4361.0250.8490.5340.6160.9920.6890.440.3120.2420.1780.171
General & Administrative Expenses 6.0837.3936.8217.355.1144.8913.7775.8173.392.8534.7683.2836.5791.8023.2712.231.9931.863.3482.2981.5861.3611.781.4731.1881.5831.5271.2030.8211.0831.0311.2060.9470.8931.3091.1330.8321.0151.0150.9860.7380.4380.2680.370.22700
Selling & Marketing Expenses 000000000000000000000000.600001.1341.3213.1580.3043.7193.3742.1690.11.2591.1130.8460.6490.2310.4550.0620.0060.05300
SG&A 6.0837.3936.8217.355.1144.8913.7775.8173.392.8534.7683.2836.5791.8023.2712.231.9931.863.3482.2981.5861.3611.782.0731.1881.5831.527-4.411.9552.4054.1896.0154.6664.2673.4793.2632.0912.1281.8611.6350.9680.8930.330.4290.280.4610.273
Other Expenses -0.111,463,7500.3640.2840.2580.35-0.005-0.525-0.185-0.087-0.1680.1280.1110.274-0.3240.055-0.073-0.0160.008-0.0360.032-0.0530.175224.2890.0320.0080.0701.1341.3213.15814.0713.7193.3742.1695.3481.2591.1130.8461,397.1570.2310.45500000
Operating Expenses 11.23813.4914.1815.57312.2349.9677.7112.6347.7727.078.1747.4769.7524.5926.0535.5185.1225.2856.527.1096.1044.2384.6644.5523.0123.7353.343.4062.5142.864.6896.8425.3434.8543.9823.6993.1162.9772.3952.2511.9611.5820.770.7410.5220.6390.444
Operating Income -0.38-14.316-14.026-15.502-12.997-9.713-7.477-13.498-7.565-6.715-7.641-7.027-9.131-4.842-5.124-3.404-6.355-5.054-5.933-5.547-4.264-4.238-3.912-4.162-2.542-3.323-3.316-3.285-2.293-2.86-4.689-6.842-5.343-4.854-3.982-3.699-3.116-2.977-2.395-2.251-1.961-1.582-0.77-0.741-0.519-0.636-0.444
Operating Income Ratio -0.525-21.764-18.313-0.002-2.173-190.524-35.197-22.015-15.083-14.614-14.186-11.649-10.746-8.164-5.682-1.703-986.963-14.757-8.463-2.695-2.317-3.707-5.198-6.783-5.398-8.081-136.785-27.058-10.414000000000000000-166.939-204.5040
Total Other Income Expenses Net -11.206-1.1261.1310.115-0.314-0.551-0.813-1.982-0.474-0.187-0.1830.001-0.155-0.594-1.2750.17-1.312-0.128-0.106-0.5320.032-0.0530.175-0.2320.0320.0080.07-0.0860.735-0.0570.080.1680.0040.004-0.0030.016-0.0130.013-0.0390.102-0.028-0.060.01-0.00800.001-0.002
Income Before Tax -11.206-14.533-12.895-15.387-13.311-10.264-8.19-13.755-7.548-6.621-7.623-6.555-8.916-4.537-6.373-3.29-6.331-4.945-5.774-5.448-4.149-4.247-3.733-4.165-2.504-3.309-3.241-3.544-1.664-3.033-4.734-6.765-5.428-4.903-4.027-3.735-3.127-2.958-2.423-2.149-1.989-1.674-0.788-0.749-0.519-0.649-0.447
Income Before Tax Ratio -15.497-22.094-16.837-0.002-2.226-201.328-38.555-22.435-15.049-14.408-14.152-10.867-10.493-7.648-7.067-1.646-983.214-14.438-8.236-2.647-2.255-3.715-4.961-6.788-5.319-8.046-133.693-29.187-7.556000000000000000-166.86-208.5950
Income Tax Expense -0.065-0.571-110,489-3.073-0.2160.4440.618-0.146-0.023-0.154-0.271-0.2940.0610.7290.817-0.1271.005-0.1870.045-0.32-0.225-0.241-0.21-1.033-0.203-0.09-0.0510.0210.0630.016-0.039-0.171-0.133-0.116-0.067-0.059-0.119-0.111-0.092-0.1580.007-0.0220.0040.0010.0490.025-0.004
Net Income -13.132-13.892110,476.105-12.314-13.095-10.708-8.121-13.563-7.433-6.543-7.532-6.452-8.852-4.454-6.292-3.337-6.195-4.771-5.715-4.938-3.659-4.05-3.527-3.132-2.301-3.219-3.19-3.472-1.617-2.925-4.56-6.487-5.185-4.713-3.909-3.611-3-2.847-2.331-2.059-1.967-1.621-0.764-0.749-0.568-0.66-0.442
Net Income Ratio -18.161-21.12144,243-0.002-2.189-210.041-38.229-22.123-14.819-14.24-13.984-10.696-10.417-7.51-6.977-1.669-962.043-13.93-8.153-2.399-1.988-3.543-4.687-5.104-4.887-7.827-131.598-28.599-7.342000000000000000-182.575-212.1690
EPS -0.5-0.534,253.8-0.48-0.51-0.42-0.32-0.54-0.3-0.26-0.31-0.29-0.43-0.35-0.77-0.7-1.29-1-1.2-1.06-1.11-1.92-5.24-3.93-4.5-6.39-8.28-10.29-5.83-11.68-34.98-53.92-43.17-39.27-40.15-38.98-32.47-30.88-25.44-22.52-28.48-64.39-28.75-28.56-21.69-26.21-17.32
EPS Diluted -0.5-0.534,253.8-0.48-0.51-0.42-0.32-0.54-0.3-0.26-0.31-0.29-0.43-0.35-0.77-0.7-1.29-1-1.2-1.06-1.11-1.92-5.24-3.93-4.5-6.39-8.28-10.29-5.75-11.53-34.52-53.22-42.61-38.76-39.63-38.47-32.04-30.48-25.11-22.32-28.11-63.55-28.37-28.19-21.4-26.21-17.32
EBITDA -0.38-11.343-13.316-14.107-11.205-8.962-6.483-10.373-6.804-6.374-7.519-6.655-8.547-3.046-4.133-3.578-3.823-4.775-5.637-4.984-4.201-4.173-3.868-3.9-2.502-3.283-3.277-3.331-2.255-2.819-4.646-6.794-5.293-4.805-3.947-3.66-3.086-2.952-2.382-2.316-1.931-1.582-0.77-0.74-0.519-0.635-0.443
EBITDA Ratio -0.525-17.244-17.386-0.002-1.873-175.792-30.518-16.918-13.565-13.873-13.959-11.034-10.059-5.134-4.582-1.79-593.651-13.943-8.041-2.422-2.283-3.651-5.14-6.356-5.313-7.984-135.204-27.438-10.238000000000000000-166.759-204.2210